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Abstract
Background: Comprehensive geriatric assessment (CGA) is an integrated model of care involving a geriatrician and
an interdisciplinary team and can prioritize and manage complex health needs of older adults with multimorbidity.
CGAs differ across healthcare settings, ranging from shared care conducted in primary care settings to specialized
inpatient units in acute care. Models of care involving geriatricians vary across healthcare settings, and it is unclear
which CGA model is most effective. Our objective is to conduct a systematic review and network meta-analysis
(NMA) to examine the comparative effectiveness of various geriatrician-led CGAs and to identify which models
improve patient and healthcare system level outcomes.
Methods: An integrated knowledge translation approach will be used and knowledge users (KUs) including patients,
caregivers, geriatricians, and healthcare policymakers will be involved throughout the review. Electronic databases
including MEDLINE, EMBASE, Cochrane library, and Ageline will be searched from inception to November 2016 to
identify relevant studies. Randomized controlled trials of older adults (≥65 years of age) that examine geriatrician-led
CGAs compared to any intervention will be included. Primary and secondary outcomes will be selected by KUs to
ensure the results are relevant to their decision-making. Two reviewers will independently screen the search results,
extract data, and assess risk of bias. Data will be synthesized using an NMA to allow for multiple comparisons using
direct (head-to-head) as well as indirect evidence. Interventions will be ranked according to their effectiveness using
surface under the cumulative ranking curve (SUCRA).
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Discussion: As the proportion of older adults grows worldwide, the demand for specialized geriatric services that help
manage complex health needs of older adults with multimorbidity will increase in many countries. Results from this
systematic review and NMA will enhance decision-making and the efficient allocation of scarce geriatric resources.
Moreover, active involvement of KUs throughout the review process will ensure the results are relevant to different
levels of decision-making.
Systematic review registration: PROSPERO CRD42014014008
Keywords: Systematic review, Network meta-analysis, Comprehensive geriatric assessment, Geriatric care, Geriatric
assessment, Integrated knowledge translation
Background
Caring for older adults (≥65 years) with complex health
and functional needs remains a challenge in healthcare.
Approximately 67% of older adults have ≥2 chronic con-
ditions and often receive care from several clinicians and
take multiple medications [1–3]. As a result, they often
experience fragmented care and are exposed to drug-
disease, drug-drug, and disease-disease interactions,
which may lead to reduced function and quality of life
[2]. Integrated models of care such as comprehensive
geriatric assessments (CGAs) can prioritize and address
the complex health needs of older adults with multimor-
bidity. CGAs focus on diagnosing and managing med-
ical, psychological, functional, and social capabilities of
older adults and involve collaboration with a geriatrician
and an interdisciplinary team [4]. CGAs occur in differ-
ent models of care across healthcare settings, ranging
from shared care in primary care settings to specialized
inpatient units in acute care settings. Given the variation
of CGAs across the healthcare continuum, it is unclear
which models are most effective to meet the needs of
older adults with multimorbidity.
Several systematic reviews suggest that CGAs can im-
prove patient outcomes. A Cochrane review of CGAs
identified 22 randomized trials; compared to usual care,
those who received a CGA in acute care settings were
more likely to remain in their home, have improved cogni-
tion and a lower risk of mortality [4]. In outpatient set-
tings, CGAs reduced functional decline and admissions to
nursing homes when compared to usual care [5]. Similar
results were also noted in geriatrician-led CGAs in re-
habilitation settings when compared to usual care [6].
While these systematic reviews suggest that CGAs can
impact patient and healthcare system outcomes, it is un-
clear which model of CGA is optimal or what the role of
the geriatrician should be in the respective models. Sev-
eral systematic reviews considered interdisciplinary
teams or unit-specific assessment (i.e., geriatric evalu-
ation and management units) for CGA but did not sep-
arate geriatrician-led CGAs from nurse or primary care
physician-led CGAs [5, 7–10]. One systematic review ex-
amined geriatrician-led CGAs in rehabilitation settings
and found a beneficial effect; however, it is unclear
whether geriatrician-led CGAs in other settings (i.e.,
acute care, long-term care) are also effective [6].
Understanding optimal roles for geriatricians across
healthcare settings is crucial, given the limited number
of geriatricians in Canada. Geriatricians belong to a sub-
specialty of internal medicine and integrate care for older
adults across multiple and often complex comorbidities,
such as geriatric syndromes, and frailty [11]. In 2015, there
were approximately 261 practicing geriatricians in Canada,
which translates to less than one geriatrician per 100,000
Canadians [12]. The ratio of geriatricians is unlikely to
increase significantly to meet the demands of the aging
population, as there were only 21 trainees in 2016 pursu-
ing this subspecialty [13]. As a result, we are faced with a
situation where the demand for specialized geriatric care
outweighs the number of specialized physicians and the
demand will only escalate in the next few years. Therefore,
it is important to understand which geriatrician-led
models of care are effective, so we can target scarce re-
sources effectively and make optimal use of geriatricians’
knowledge and skills.
To address this gap, we plan to conduct a systematic
review and network meta-analysis (NMA) to determine
the comparative effectiveness of geriatrician-led CGAs
across healthcare settings. An integrated knowledge
translation (iKT) approach will be used and knowledge
users (KUs), such as patients, caregivers, geriatricians,
and policymakers, will be engaged throughout. Our re-
search question is: For adults aged ≥65 years, what is the
comparative effectiveness of geriatrician-led models of
care for improving patient-level (e.g., function, quality of
life, caregiver stress) and healthcare system-level (e.g.,
admission to long-term care) outcomes?
Methods
The systematic review and NMA will be conducted
using methods established by the Cochrane Collabor-
ation [14]. To facilitate uptake and to ensure results are
applicable to multiple levels of decision-making, an iKT
approach will be used to engage KUs in the review
process. To guide KU engagement, the Stakeholder
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Engagement in Comparative Effectiveness Research
(SECER) Framework will be used [15, 16]. The SECER
framework postulates that KUs will be more engaged in
research when results are deliberated, contextualized,
and aligned with their values and preferences, the full
framework is presented in Additional file 1 [16]. To ac-
complish this, we have embedded several qualitative
components within the systematic review process to seek
KU preferences and values. Our systematic review will
be conducted in several stages.
Part 1—Systematic review protocol
The protocol was drafted according to the PRISMA
protocol statement [17], and revised with feedback from
geriatricians, a systematic review methodologist, and a
statistician. The final protocol was registered with
PROSPERO (CRD42014014008) [18].
Eligibility criteria
Randomized controlled trials (RCTs) that include adults
aged ≥65 years from all healthcare settings (e.g., primary
care, acute care, long-term care, and rehabilitation) are
eligible. RCTs were selected, as they are the most vali-
dated study design for evaluating the effectiveness of
healthcare interventions [19, 20]. The intervention must
focus on a geriatrician-led care model (e.g., solo member,
team-based interventions) across the healthcare con-
tinuum, such as clinics (e.g., shared care with primary
care), home visits, inpatient consultation, inpatient and
outpatient rehabilitation, day hospital, telehealth, and
acute inpatient units. Care must focus on CGA, including
assessment and management of medical, psychological,
functional, and social capability. Standard care or other
care models (geriatrician-led or not) will be considered as
comparators. Primary and secondary outcomes will be
selected by KUs to ensure the review is relevant for their
decision making. Potential patient outcomes may include
cognition, function (basic and instrumental activities of
daily living), quality of life, caregiver stress, and patient
satisfaction. Potential healthcare system level outcomes
may include: number of patients living at home (inverse of
death or living in residential care [4]), number of emer-
gency department visits, number of acute care admis-
sions, admission to long-term care, death, length of
stay in acute care, number of outpatient visits, health-
care utilization, and number of physician visits. No re-
strictions will be placed on the year of publication,
language, or publication status. Eligibility criteria are
presented in Additional file 2.
Information sources and literature search
A comprehensive literature search will be conducted by
an experienced librarian (Ms. Becky Skidmore) in con-
sultation with the research team. Electronic databases
including MEDLINE, EMBASE, Cochrane Library, and
Ageline will be searched from inception to November
2016, using keywords such as “geriatric assessment”,
“health services for the aged”, and “comprehensive
health care”. A draft search strategy is presented in
Additional file 3. The literature search will be peer
reviewed by another information specialist (Ms. Heather
MacDonald) using the PRESS checklist and modified ac-
cordingly [21]. To supplement our electronic search strat-
egy, we will search clinical trial databases such as BioMed
Central ISRCTN registry or the National Institutes of
Health clinical trial registry, as well as conference pro-
ceedings from relevant organizations such as the Canadian
Geriatric Society, Canadian Association of Gerontology,
and the International Association of Gerontology and
Geriatrics to identify unpublished trials. In addition, we
will scan the reference lists of included studies to obtain
RCTs not captured by our literature search.
Study selection process
The search results will be uploaded to Synthesi.SR [22], a
proprietary systematic review software owned by the
Knowledge Translation Program at St. Michael’s Hospital.
It allows screening of citations and full-text articles by
multiple reviewers simultaneously. Prior to reviewing
search results, a pilot test of 150 citations will be con-
ducted to ensure reliability amongst reviewers. Inter-rater
reliability will be assessed using percent agreement and
>80% will be indicative of good reliability amongst re-
viewers. Two reviewers will subsequently screen titles/ab-
stracts and full-text articles for inclusion independently.
Discrepancies will be mediated by a third reviewer.
Charting
After relevant studies are identified, the outcomes and
outcome measures reported in CGA studies will be
charted in Excel. A description of variables captured in
the charting file is presented in Additional file 4. The pur-
pose of charting is to identify which outcome measures
are reported in the literature so that KUs can select the
outcomes that are most relevant for their decision-
making. Additional PICO elements (i.e., the length of
study, the number of time points, comorbid conditions)
will be abstracted but will only be used to inform the full
data abstract form and potential statistical analyses.
Part 2—Selection of outcomes and measures for
inclusion in systematic review
Knowledge users
Patients, caregivers, geriatricians, and policymakers will
be invited to participate as KUs. Patients and caregivers
will be recruited from the Elders’ Clinic at St. Michael’s
Hospital and will be approached if they have had a CGA
in the last year and do not have a diagnosis of dementia.
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Geriatricians will be recruited through the Division of
Geriatric Medicine, University of Toronto, and policy-
makers or healthcare managers will be recruited from
the Regional Geriatrics Program of Ontario, Health
Quality Ontario and decision makers associated with the
Council of Academic Hospitals of Ontario. We hope to
engage 30 KUs in the systematic review process. Ethics
approval was obtained from St. Michael’s Hospital and
the University of Toronto.
Delphi process to select relevant outcomes
A modified Delphi approach with two rounds will be
used to achieve consensus on which outcomes should be
considered for inclusion [23]. First, an online survey will
be sent to KUs (via Qualtrics [24]) with a list of all out-
comes reported in the CGA literature. Additional con-
siderations will be made for patients and caregivers, as
they may not have email access, or feel comfortable
using the online platform. A research assistant will be
available to help patients and caregivers with the survey
either by phone or in person. KUs will rate the import-
ance of each outcome on a 7-point Likert scale ranging
from “not at all important” to “extremely important”.
Ratings will be aggregated and median ratings along with
interquartile ranges will be calculated. Outcomes with
median ratings of ≥5 will be considered important out-
comes for decision-making and move on to the second
round. In the second round, KUs will rate the shortened
list of preferred outcomes using the same scale. The
two-step elimination approach will ensure that only the
outcomes that are most relevant to their decision-
making needs are included in the systematic review.
Survey to select appropriate outcome measures
After outcomes are selected, an online cross-sectional
survey with geriatricians will be conducted to identify
optimal validated measures for each outcome. Patients,
caregivers, and policymakers typically do not use these
measures and will not participate. Only continuous
patient-level outcomes (i.e., cognition, function, quality
of life) will be included in the survey, as there are many
ways these outcomes can be measured. For example, in
a previous charting exercise of Alzheimer’s dementia,
>70 outcome measures were identified in the literature
for assessing cognition [25]. It is not feasible to abstract
data on all of these measures and similarly, this is not
practical for NMA. As such, we feel this additional step
will streamline data abstraction for continuous outcomes
and reduce outcome heterogeneity in statistical analyses.
Geriatricians will rate the outcome measures using the
same approach that was used for selecting outcomes,
with a 7-point Likert ranging from “not at all important”
to “extremely important”. Validated outcome measures
with median ratings of ≥5 will be considered for
inclusion in the systematic review, increasing the rele-
vance of results.
Part 3—Completion of the systematic review
Data abstraction
A standardized data abstraction form will be created and
tailored to outcome measures selected in part 2. The
form will include study characteristics (e.g., study design,
year trial conducted, sample size, setting, country of trial
conduct, intervention, and comparator details), patient
characteristics (e.g., type and number of patients, mean
age and standard deviation, co-morbidities), intervention
characteristics (e.g., role of geriatrician on team, mem-
bers of the care team, care setting), and outcomes se-
lected by KUs (e.g., number of events per treatment
arm, means, standard deviation).
The data abstraction form will be piloted with the re-
view team using a random sample of 10 included RCTs
and modified as needed. Data abstraction will begin
when sufficient agreement is noted (i.e., percent agree-
ment >80%). To ensure accuracy, two reviewers will in-
dependently abstract all data using the standardized
form in Excel; discrepancies will be resolved by a third
reviewer, who will verify all data. In some studies, out-
come results will be reported over many time periods
but only the longest duration will be abstracted [14].
Multiple publications may report data from the same
study group (i.e., companion reports). When this occurs,
data will only be abstracted for the longest duration if
different from the original study to avoid duplicate pub-
lication bias. Information captured from companion re-
ports will be used for supplementary data only. Authors
will be contacted to obtain missing data such as details
of the study setting, or intervention (e.g., the role of
geriatrician, frequency of assessments).
Methodological quality and risk of bias assessment
Risk of bias will be assessed using the Cochrane Risk of
Bias Tool [26]. The tool considers the internal validity of
included RCTs and focuses on random sequence, alloca-
tion concealment, blinding of participants and personnel,
incomplete outcome data, selective reporting, and other
sources of bias (i.e., funding bias). To assess the ex-
tent of publication bias, comparison-adjusted funnel
plots will be used when more than 10 studies are
available [27]. Comparison-adjusted funnel plots are
an extension of funnel plots and account for multiple
pair-wise comparisons [27].
Data synthesis
The results from the systematic review will be summa-
rized descriptively and study characteristics, patient
characteristics, risk of bias results, and frequencies of
outcomes across the included RCTs will be reported.
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Meta-analysis
A Bayesian meta-analysis (MA) will be conducted to
examine pairwise comparisons. Bayesian MA offers
some advantages over traditional frequentist methods as
parameter uncertainty is automatically accounted for in
the analysis and a Bayesian approach can facilitate prob-
abilistic statements which can enhance decision making
[28]. In addition, the approach allows for direct compari-
son between mixed treatment comparisons in the NMA
and direct head-to-head results from MA [28]. MA will
be conducted whenever two or more studies compare
the same two interventions and comparators for the
same outcome. We expect that study and patient character-
istics will differ across trials and we will apply a random
effects model to incorporate anticipated heterogeneity. Stat-
istical heterogeneity will be evaluated using the I2 statistic.
If significant statistical heterogeneity is observed (e.g., I2 >
75%), a meta-regression and/or subgroup analysis will be
conducted [29]. The meta-regression will explore the
influence baseline effect sizes; age, frailty, comorbidities,
cognition, function, setting (all sources of clinical hetero-
geneity); and risk of bias results (source of methodological
heterogeneity) on MA results. The number of covariates
examined will be constrained to one tenth of the number
of studies to avoid type II errors [30]. If a meta-regression
is not possible (<10 studies), subgroup analyses will be used
to explore the sources of clinical and methodological het-
erogeneity on results. Potential subgroups that may be ex-
plored include care setting (primary versus other), the role
of the geriatrician (shared care versus most responsible
physician), risk of bias (high versus low), and attrition rate
(<10 versus ≥10%). Some RCTs will not report relevant data
(e.g., standard deviations) needed for analysis, and to in-
clude these in the analysis, missing continuous data will be
imputed using established methods [31].
The Bayesian MA will be conducted in OpenBUGS [32].
Results will be reported as odds ratios for dichotomous out-
comes or mean difference for continuous outcomes, along
with 95% credible intervals based on 100,000 Markov chain
Monte Carlo simulations after a burn in of at least 50,000
simulations and vague priors. The aim of the vague prior is
to elicit comparable results that would have been obtained
through frequentist inference; however, results may be sen-
sitive to vague priors [33]. To examine this influence of
priors on point estimates, sensitivity analyses will be con-
ducted using different priors. Model convergence will be
assessed using the trace and history plot functions in Open-
BUGS, as well as the Brooks-Gelman-Rubin (BGR) statistic
[34]. Forest plots will be generated using the metafor pack-
age in R statistical program [35].
Network meta-analysis
If appropriate, a Bayesian NMA will be conducted to
synthesize results for each outcome. Nodes in the NMAs
will represent the various geriatrician-led care models.
CGAs are complex interventions that are often tailored
to individual needs and implemented in different health-
care settings. We will define nodes to lessen the potential
heterogeneity in the network. The role of the geriatrician
and the healthcare setting of the CGA are known factors
that contribute to the diversity of CGAs. Geriatricians will
be consulted during node categorization to ensure that
similar geriatrician roles are grouped together, which will
aid in the clinical interpretation of results. Depending on
the breadth of included studies and the extent of hetero-
geneity examined by simple classification, we may also
consider dividing the nodes further into components and
examine the members of the multidisciplinary teams and
the frequency of contact with the multidisciplinary team
and geriatrician.
For NMA results to be valid, assumptions of compar-
ability, such as connectivity, transitivity, and consistency
need to be considered [36]. Connectivity refers to how
well the studies form a connected network and will be
visualized using network diagrams [37]. Although there
is no formal definition of what constitutes a connected
network, the following will be used as a guide; a con-
nected network should link the different interventions
from each study and enable the connection of at least
two interventions in the evidence base, and for every
two studies, there should be at least one common com-
parator. Sparse or unconnected networks are not suit-
able for NMA, due to the heavy reliance on indirect
evidence and will be assessed on their network geom-
etry [38]. Once connectivity is observed, transitivity will
be explored, which allows us to make indirect compari-
sons by way of a common comparator (i.e., standard
care) [36]. To assess whether indirect comparisons are
valid, we will color the edges in the NMA diagram to
represent patient and study characteristics and assess
visually whether there is an equal distribution of these
characteristics across the interventions [36]. Patient
and study characteristics that we anticipate may influ-
ence transitivity include frailty, comorbid conditions,
gender, and healthcare setting (i.e., acute care, long-
term care settings). The consistency of the results from
direct evidence (i.e., head-to-head trials from pairwise
MA) versus indirect evidence (i.e., from NMA) will be
compared using the design-by-treatment model [39],
which assesses global inconsistency across the network.
If global inconsistency is observed, we will check for
data abstraction errors and if none exist, we will ex-
plore local inconsistency using the loop-specific
method [40]. If inconsistency is still observed, we will
conduct meta-regression and/or subgroup analysis. Po-
tential meta-regression or subgroup analyses that we
may explore will include age, frailty, cognition, func-
tional status, attrition (<10 versus ≥10%), care setting
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(acute care, primary care, long-term care settings), and
risk of bias (high versus low).
All NMAs will be conducted in OpenBUGS [32]
Bayesian statistical software. Results will be reported as
odds ratios for dichotomous outcomes or mean differ-
ence for continuous outcomes, along with 95% credible
intervals based on 100,000 Markov chain Monte Carlo
simulations after a burn in of at least 50,000 simulations
and vague priors. Model convergence will be assessed
using the trace and history plot functions in OpenBUGS,
as well as the Brooks-Gelman-Rubin (BGR) statistic [34].
Predictive intervals will be calculated, which gives an in-
dication of how the results will change if a new trial is
conducted in the future and added to the evidence. The
effectiveness of care models will be ranked using surface
under the cumulative ranking (SUCRA) curve [37]. Sen-
sitivity analysis will be conducted to examine the effects
of imputations for missing data [31].
Dissemination
After analysis, KUs will participate in a 1-day meeting to
discuss the results. A nominal group technique will be
used to develop the key messages for each KU group
(i.e., patients/caregivers, clinicians, and policymakers)
[41]. Specifically, all NMA results will be presented to
KUs at the meeting and they will work in small groups
to create the key messages and develop the dissemin-
ation strategy for each audience. Key messages will be
highlighted in the final systematic review manuscript.
At the end of the 1-day meeting, KUs will complete the
patient and public engagement questionnaire (PPEQ),
which is an online survey to quantify engagement [42]. It
uses criteria from the SECER framework and is a process
measure that provides a qualitative indication of how en-
gaged KUs feel in the research process [16]. Use of the
PPEQ is novel to systematic reviews but has the potential
to provide empirical evidence for the impact of the iKT
process. Use of the questionnaire will allow us to under-
stand if surveys, nominal group technique, or Delphi’s are
effective methods to engage stakeholders in the systematic
review process.
The dissemination strategy will be informed by the
Knowledge-to-Action framework [43]. A spectrum of
end-of-grant knowledge translation strategies will be ex-
plored and will be tailored to different audiences. Our
strategy will include passive dissemination via publica-
tion in peer-reviewed journals, the creation of know-
ledge tools (such as slide decks for our KUs to use in
their dissemination activities as knowledge brokers), and
activities such as providing interactive workshops and
videos. Our approach is as follows: the design of key
messages will be clear, simple, action-oriented, and tai-
lored for each KU audience; sources of the message will
be individuals that are influential and credible with each
target audience (i.e., KUs as knowledge brokers); and
dissemination approaches will be KU-driven and tailored
to how and when they want to receive information.
Discussion
Geriatrician-led CGAs have the potential to help older
adults manage complex healthcare needs; however, their
effectiveness is unclear. Several systematic reviews have
examined CGAs across healthcare settings; however, it is
still unclear which model is most effective or what the role
of the geriatrician should be in the respective models.
There is a lack of head-to-head trials in the CGA literature
and our systematic review can overcome some of the limi-
tations of previous reviews and meta-analyses through the
use of NMA. NMA explores comparative effectiveness by
using the totality of information available and compares
interventions that have not been assessed in head-to-head
studies. Using direct and indirect evidence in an NMA
can increase power and precision of estimators. In
addition, the approach allows us to rank the interventions
in terms of probability of being the most effective or
safest, which can facilitate informed decision-making.
The iKT approach will actively engage KUs in the
research process, by selecting relevant outcomes and
measures for inclusion in the review and analysis. In
addition, KUs will identify the key messages resulting
from the review and the information can be used to in-
form implementation and dissemination strategies, such
as patient decision aids or clinical practice guidelines,
which will have a direct impact on the delivery of
healthcare. Additionally, this will help refine knowledge
products and help to further increase the uptake of re-
search findings stemming from the systematic review
and NMA.
Limitations and challenges
The current study is a large and comprehensive review
of CGAs and there are several limitations and challenges
to our methods. First, in the data abstraction phase of
our systematic review, we are only abstracting data on
the longest duration of follow-up, which may inadvert-
ently contribute to a lack of consistency across studies
and result in heterogeneity in MA or NMA applications.
However, if there is a robust amount of studies reporting
multiple time points we may consider conducting several
analyses stratified by length of duration. In addition, we
will not be able to explore intervention effects over time
(e.g., 3 months versus 6 months). We anticipate some
degree of inconsistency and have taken steps to limit un-
due heterogeneity in data, such as selecting appropriate
outcomes measures which may reduce outcome hetero-
geneity. We feel this approach is conservative and will
make data abstraction streamlined and will enable us to
conduct an NMA.
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Second, our NMA considers the assumptions under-
lying the statistical approach; however, the data may
violate these assumptions and it may not be feasible or
appropriate to conduct an NMA. If an NMA is not
possible, we will report on the synthesis results for all
pairwise comparisons using Bayesian MA. The MA will
provide an update of results from previous systematic
reviews and we will examine differences in point esti-
mates from previous analyses. Connectivity and transi-
tivity assumptions are contingent on the similarity of
interventions within nodes. Our nodes represent the role
of the geriatrician in the respective models of care and
may not be explicitly stated in the trials; as such, it may
be difficult to categorize nodes and will make the syn-
thesis of evidence a challenge. To overcome this, we will
consult with geriatricians during the process of node
categorization to increase the chances of creating clinic-
ally relevant nodes.
Lastly, we plan on recruiting 30 knowledge users
(KUs) to be part of the systematic review process. KUs
will not screen search results, abstract data, or assist
with critical appraisal. KUs will provide input along the
way and will contribute to the overall direction of the
systematic review. This may limit their engagement in
the process as they will not be involved in all steps of
the systematic review. We felt this approach was most
feasible, as it did not require any training or require
major time commitments and is an adequate level of
engagement that will be useful to the review and KUs.
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